Search

everythinglearnresearchcommunity

for

Search:↓

Levetiracetam often causes behavioral issues, while oxcarbazepine is more likely to cause sleepiness in epilepsy patients.

Entospletinib effectively prevents eye and skin GVHD in mice.

Voglibose may help treat skin hyperpigmentation safely.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

The FDA rejected a testosterone drug again due to safety concerns.

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

A child with a rare vitamin D-resistant condition improved with treatment.

Vitamin D Receptor is crucial for hair follicle shrinkage and cell death, affecting hair growth.

NB-UVB phototherapy is an effective and safe treatment for vitiligo, especially on hands and feet, and can be improved with tacrolimus.

Valproic acid can cause serious side effects, including pancreatitis and even death.

Growth hormone therapy can improve symptoms and growth in children with Vitamin-D Dependent Rickets Type-2.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

COVID-19 treatments and vaccines face challenges due to genetic differences in people and the virus.

Early screening and HPV vaccination reduce cervical cancer risk.

Atorvastatin may cause hair loss in some people.

ZD1839 can cause skin issues like acne and hair changes.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Expressing the human vitamin D receptor in skin cells prevents hair loss in certain mice.

Glycyrrhizinic acid spray showed limited effectiveness in treating anogenital warts in HIV patients with low CD4 levels.

Plasmatherapy improves immune status in vitiligo patients, especially those with segmental vitiligo.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Tunisian children with hereditary vitamin D-resistant rickets showed improvement with calcium treatment, and new genetic mutations were identified.

Flutamide reduces hair growth better but has more side effects.

More effective treatments are needed for alopecia areata, hidradenitis suppurativa, and vitiligo.

Verilich hair serum significantly reduces hair shedding and is safe to use.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.